Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sangani HospitalsNSE:SANGANI -2.30%81 EBITDA Margin % is 8.15% as of Mar. 2026, which is 59% below its 10-year median of 19.89. GuruFocus rates NSE:SANGANI with a GF Score™ of 81/100 and a GF Value™ of ₹303.41 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Sangani Hospitals ranks worse than 57.14% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sangani Hospitals's EBITDA for the
six
months ended in Mar. 2026 was ₹70 Mil. Sangani Hospitals's Revenue for the
six
months ended in Mar. 2026 was ₹865 Mil. Therefore, Sangani Hospitals's EBITDA margin for the quarter that ended in Mar. 2026 was 8.15%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sangani Hospitals EBITDA Margin % Related Terms
Sangani Hospitals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sangani Hospitals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SANGANI vs HCA, THC, EHC: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Sangani Hospitals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sangani Hospitals EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sangani Hospitals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sangani Hospitals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sangani Hospitals (NSE:SANGANI) has a EBITDA Margin % of 8.15% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sangani Hospitals and its competitors. This is 59% below median its historical median of 19.89. Over the past decade, Sangani Hospitals' EBITDA Margin % has ranged from 8.12 to 29.89. According to the industry distribution chart, Sangani Hospitals ranks #384 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 57.1%.
Is Sangani Hospitals' EBITDA Margin % too high?
Sangani Hospitals' current EBITDA Margin % of 8.15% is 59% below median its 10-year median of 19.89. Over the past 10 years, this metric has ranged from a low of 8.12 to a high of 29.89. The Healthcare Providers & Services industry median EBITDA Margin % is 10.18. Sangani Hospitals' value of 8.15% is 19.9% below this industry median. Based on the distribution chart, Sangani Hospitals ranks #384 out of 672 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sangani Hospitals has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sangani Hospitals' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sangani Hospitals ranks #384 out of 672 companies for EBITDA Margin %. This places Sangani Hospitals in the lower half of its industry. The industry median EBITDA Margin % is 10.18. Sangani Hospitals' value of 8.15% is 19.9% below this benchmark. Historically, Sangani Hospitals' own EBITDA Margin % has ranged from 8.12 to 29.89 over the past decade. While the company's 10-year median is 19.89 vs. the industry median of 10.18, Sangani Hospitals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.18, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sangani Hospitals's current EBITDA Margin % of 8.15% is 19.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sangani Hospitals and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sangani Hospitals's current EBITDA Margin % is 8.15%, which is 59% below median its own 10-year median of 19.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangani Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Sangani Hospitals (NSE:SANGANI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹303.41, compared to a current price of ₹48.75 — trading 83.9% below its estimated fair value. The current EBITDA Margin % is 8.15%, which is 59% below median its 10-year median of 19.89 and 19.9% below the Healthcare Providers & Services industry median of 10.18. Sangani Hospitals' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sangani Hospitals (NSE:SANGANI), the current EBITDA Margin % is 8.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sangani Hospitals (NSE:SANGANI) Overvalued in 2026?
Based on GuruFocus' analysis, Sangani Hospitals stock appears to be undervalued.
The current stock price of ₹48.75 is trading 83.9% below its estimated GF Value™ of ₹303.41.
GuruFocus considers Sangani Hospitals to be Possible Value Trap.
Key valuation signals for NSE:SANGANI:
EBITDA Margin %: 8.15% (59% below median its 10-year median of 19.89)
GF Value™: ₹303.41 vs. price of ₹48.75 (83.9% below fair value)
Industry Position: 19.9% below the Healthcare Providers & Services median (#384 of 672)
No single metric tells the full story. See the NSE:SANGANI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sangani Hospitals Ltd is a multi-specialty healthcare provider operating in the Keshod and Veraval regions of Gujarat. Its services predominantly include super specialty services, specialty services, and other support services. It also operates a pathology laboratory and medical store. Currently, it operates out of two hospitals i.e. Sangani Hospital at Keshod, Junagadh, Gujarat and Sangani Super Speciality Hospital, Veraval, Gujarat. The company operates in a single segment, which is Healthcare. The company operates departments and units, including General Medicine, ENT, Dialysis, Orthopedics, General Surgery, Urosurgery, Trauma, and Physiotherapy.
81GF Score
Get the complete analysis for NSE:SANGANI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANGANI has been successfully added to your 
